In summary, administration of SCTE in this mouse asthma model significantly decreased the number of eosinophils in BALF and lung tissue, and reduced IL-4 IL-5, IL-13, TNF-α, and eotaxin production in BALF and total IgE and OVA-specific IgE levels in plasma after OVA challenge. This evidence concerns the gene TNF and asthma.